EFSD Applicant Report
Total Page：16
File Type：pdf, Size：1020Kb
FUNDING DIABETES RESEARCH SINCE 2000 For Potential Grant Applicants European Foundation EFSD for the Study of Diabetes European Foundation EFSD for the Study of Diabetes FUNDING DIABETES RESEARCH SINCE 2000 Foreword EFSD operates on a strictly non-profit basis of the researchers that we have funded over working tirelessly in association with many the years. It is an opportunity for us all to reflect of the world’s leadingGRANTS pharmaceutical and & FELLOWSHIPSon our progress and how you have helped us biotechnology companies to offer an array with our mission to enhance awareness of of different funding streams to young and the severity of diabetes and the magnitude establishedAVAILABLE researchers alike. THROUGHOUTof this devastating THE disease YEAR across Europe. Over the years, our successful fundraising It is only through research that we can do this. President: Stefano Del Prato, Italy strategy has allowed us to commit in excess As we move forwards, our goal is to continue of 100 million Euros to diabetes research and to partner with as many companies and Chairman: Michael Roden, Germany we havewww.EuropeanDiabetesFoundation.org grown to become one of the most organisations as we can to ensure that we significant funding agencies for diabetes offer new funding streams that are as relevant Members of the EFSD Scientific Board: research in Europe. As we look back on what to today’s research needs and that attract Tadej Battelino, Slovenia Paola Fioretto, Italy we have achieved, we are heartened to see the very best grant applications as they were Matthias Blüher, Germany Hasan Al-Hasani, Germany the impact that our funding has had. We have when we started our mission to fund the best Andrew Boulton, UK Nebojsa Lalic, Serbia helped countless researchers to progress their research that we could. Its other main purpose Fatima Bosch, Spain Michael Nauck, Germany careers in science and medicine and we’ve is to encourage you to apply for funding and Marc Donath, Switzerland Ulf Smith, Sweden been acknowledged as a funder of research to help you put together the best possible Francesco Dotta, Italy Apostolos Tsapas, Greece in some of the highest impact journals application. We hope you find this document Gian Paolo Fadini, Italy Juleen Zierath, Sweden in the world. interesting and helpful, and good luck in your Massimo Federici, Italy application to EFSD! This publication has been designed to celebrate Managing Director and Chief Medical Officer:Monika Grüsser, Germany these successes and to introduce you to some 2 3 Countries where EFSD has awarded funding to diabetes researchers 4 5 History of the European Foundation Cumulative spend on diabetes research for the Study of Diabetes 100 In 2000, the European Association for the Study of Diabetes (EASD) increased its commitment to stimulate diabetes research in Europe by creating the European Foundation for the Study of Diabetes (EFSD). 80 EASD recognised that, although diabetes research was strong across the 60 entire continent, the scientific funding opportunities varied considerably from country to country. 40 The EFSD was created as a separate legal entity and funding was sought from the pharmaceutical and biotechnology sectors with invitations to 20 co-fund innovative research programmes. In addition to funding research Cumulative Spend (Million Euros) programmes on its own, these unique relationships with industry allowed EFSD to leverage substantial funds into its research portfolio. EFSD has also 0 Professor Philippe Halban collaborated with other organisations to develop highly successful research programmes focused on areas of common interest. 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 Honorary Chairman, EFSD Since it began, EFSD has committed over 100 million Euros to diabetes research across Europe and beyond. The Foundation has now become a “When we set up EFSD, “EFSD’s great strength over significant European funding agency for diabetes research, and is continually we knew that to prove our the years has come from striving to enhance diabetes awareness in Europe. There is an urgent need business case, we needed its relationships with the for more research to improve its treatment, management and prevention, to attract industry partners pharmaceutical and biotech and, ultimately, to find a cure. to work with us to allow sectors which have allowed Today, EFSD offers funding in all areas of diabetes research through a wide the Foundation to fund it to co-fund a wide variety range of joint and stand-alone initiatives. Grant programmes offer funding for research. In these early of research initiatives. researchers working in Europe and associated countries while travel fellowships are open to scientists worldwide. All applications are subject to years, we just wanted good When we started, there was peer review by a panel of leading experts. applications from good just a small amount of researchers. Almost 20 money available for years later, we’re still doing educational and research it and the organisation is purposes but now, thanks The aims of the European Foundation for the inundated with hundreds to the hard work of so Study of Diabetes are to encourage and support of excellent applications many people, EFSD has groundbreaking diabetes research and to promote every year. EFSD has now grown considerably and the next generation of leading diabetes researchers. grown into a very significant become a phenomenal European funding agency catalyst for diabetes for diabetes research”. research across Europe”. Professor Jørn Nerup Professor George Alberti President (1998-2001) President (1992-1995) 6 7 Timeline for EFSD Grant Programmes Application form and guidelines Application written and Outcome of Outcome of downloaded from EFSD website submitted for grant deadline triage notified grant application notified No feedback DEADLINE is given to the APPLICANT unsuccessful applicant at this stage MONTHS 4 3 2 1 1 2 3 4 Applications EASD/EFSD on the EFSD website checked and Review Board entered onto Triage Committee agreement Inform database completed Full review Meeting and sign-off applicants Call for applications published Review committee formed 1-2 WEEKS 5-6 WEEKS 5-6 WEEKS 1 DAY 2-3 DAYS 2-3 DAYS DEADLINE EFSD Diabetologists who specialise in the focus area THE EFSD All applications At the end of each Successful applicants of the call are approached and asked to be part Programme Board to be reviewed individual discussion are advised and grant of the review committee team. One of them ensures that all in full are sent to during the review activation documentation will also be asked to chair the committee. applications are the nominated committee meeting, is sent. Only those passing reviewed by up reviewers, who a final score is taken triage will receive feedback to three members are given the from all members of on their proposal. of the review applications that the committee, and committee who best match their the mean score is have declared no area of expertise. calculated. This conflicts of interest. Each application process allows the They score each is reviewed by a reviewers to reach of the applications primary and a a mutual agreement assigned to them. secondary reviewer, on which applications A cut-off is then who provide to fund. decided, dependent in-depth and upon the quality strategic written of the applications reviews. They are and the number also asked to read of grant awards the remaining available. applications and to form an opinion on them so they can contribute to the committee meeting discussions. 8 9 Professor Michael Roden Professor Decio L. Eizirik German Diabetes Center, Düsseldorf, Germany Université Libre de Bruxelles, Brussels, Belgium Minkowski Prize Winner, 2006 EASD Albert Renold Prize Winner, 2012 Professor Michael Roden has been funded by EFSD Professor Decio L. Eizirik has held several EFSD grants on a number of occasions between 2002 and 2009. from a Lilly Fellowship award in 1999 to a JDRF/Novo “I was encouraged to apply to EFSD because the funding Nordisk Programme in Type 1 Diabetes Research streams that were being advertised were offering award in 2010. “The EFSD initiative was a brilliant attractive amounts of money to allow researchers to idea and one that has helped many of us working in expand their research portfolio and, for me, the grants diabetes research over the years. The funding is allowed me continuity in my research and bridged particularly useful for targeted research. And it’s funding gaps early in my career. EFSD is an incredibly prestigious as well, as it has helped younger well recognised international funder so becoming an colleagues from our centre to secure larger grants awardee contributed to my reputation and visibility from other funding agencies and, eventually, to obtain within the diabetes field and helped me to leverage tenured positions”. additional funding from other organisations”. “EFSD provides a very valuable and prestigious source of grant money. The very positive and fair feedback that I have received from the grant evaluation committee over the years has Professor Apostolos Tsapas been incredibly useful and the awards have Aristotle University Thessaloniki, Greece definitely helped my career development” Professor Anders Tengholm “The Albert Renold Fellowship has been instrumental Uppsala University, Sweden for my personal development in the field of diabetes. It offered me the chance to see research and clinical practice in a world-class centre of excellence in “The Rising Star Fellowship helped me not only diabetes, but also the stimuli to train and acquire novel to build my profile within the diabetes expertise in the field of evidence-based healthcare. The EFSD has a number of awards, some big and community and to get a tenured position but some small. The Albert Renold Fellowship can support also to get additional funding. I very much hope young researchers to get new skills but, in addition, that EFSD continues to fund this kind of there are calls for much bigger grants.